Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The CCA-adding enzyme has a single active site

D Yue1, A M Weiner, N Maizels

  • 1Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, Connecticut 06520-8024, USA.

The Journal of Biological Chemistry
|October 29, 1998
PubMed
Summary

The CCA-adding enzyme uses a single active site to add both C and A nucleotides to tRNA. Specificity is achieved through collaborative templating as the tRNA refolds during the addition process.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer: final analysis of the randomized RATIONALE-315 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Correction: IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma.

Oncogene·2023
Same author

Improvements in Air Quality and Health Outcomes Among California Medicaid Enrollees Due to Goods Movement Actions.

Research report (Health Effects Institute)·2022
Same author

Efficient compressive and Bayesian characterization of biphoton frequency spectra.

Optics letters·2020
Same author

IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma.

Oncogene·2017
Same author

Aurora-A-mediated phosphorylation of LKB1 compromises LKB1/AMPK signaling axis to facilitate NSCLC growth and migration.

Oncogene·2017

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Enzymology

Background:

  • The CCA-adding enzyme (tRNA nucleotidyltransferase) is crucial for tRNA synthesis and repair.
  • This enzyme belongs to the nucleotidyltransferase superfamily, sharing a conserved active-site motif across all domains of life.

Purpose of the Study:

  • To investigate the catalytic mechanism of the CCA-adding enzyme.
  • To determine if a single active site is responsible for adding both C and A nucleotides.
  • To elucidate the mechanism of nucleotide addition specificity.

Main Methods:

  • Site-directed mutagenesis of key residues (Asp-53, Asp-55, Asp-106, Glu-173, Asp-215) in the Sulfolobus shibatae CCA-adding enzyme.
  • Assessing the effect of mutations on the addition of C and A nucleotides to tRNA.

Main Results:

  • Mutations at Asp-53 or Asp-55 abolished the addition of both C and A, confirming a single active site.
  • Mutations at Asp-106 selectively impaired A addition, but not C addition.
  • Previous findings showed the tRNA acceptor stem remains fixed during catalysis.

Conclusions:

  • The CCA-adding enzyme utilizes a single active site for the sequential addition of C and A nucleotides.
  • Nucleotide addition specificity is governed by a collaborative templating mechanism involving progressive refolding of the tRNA 3'-end.
  • This mechanism ensures accurate CCA sequence synthesis essential for tRNA function.

Related Experiment Videos